Targeted therapy of pulmonary arterial hypertension: updated recommendations from the Cologne Consensus Conference 2018

In the summer of 2016, delegates from the German Respiratory Society, the German Society of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to define consensus-based practice recommendations for the management of patients with pulmonary arterial hypertension (PAH)....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Höper, Marius (VerfasserIn) , Apitz, Christian (VerfasserIn) , Grünig, Ekkehard (VerfasserIn) , Halank, Michael (VerfasserIn) , Ewert, Ralf (VerfasserIn) , Kaemmerer, Harald (VerfasserIn) , Kabitz, Hans-Joachim (VerfasserIn) , Kähler, Christian (VerfasserIn) , Klose, Hans (VerfasserIn) , Leuchte, Hanno (VerfasserIn) , Ulrich, Silvia (VerfasserIn) , Olsson, Karen M. (VerfasserIn) , Distler, Oliver (VerfasserIn) , Rosenkranz, Stephan (VerfasserIn) , Ghofrani, H. Ardeschir (VerfasserIn)
Dokumenttyp: Article (Journal) Konferenzschrift
Sprache:Englisch
Veröffentlicht: 25 August 2018
In: International journal of cardiology
Year: 2018, Jahrgang: 272, Pages: 37-45
ISSN:1874-1754
DOI:10.1016/j.ijcard.2018.08.082
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.ijcard.2018.08.082
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0167527318343493
Volltext
Verfasserangaben:Marius M. Hoeper, Christian Apitz, Ekkehard Grünig, Michael Halank, Ralf Ewert, Harald Kaemmerer, Hans-Joachim Kabitz, Christian Kähler, Hans Klose, Hanno Leuchte, Silvia Ulrich, Karen M. Olsson, Oliver Distler, Stephan Rosenkranz, H. Ardeschir Ghofrani

MARC

LEADER 00000caa a2200000 c 4500
001 1691563080
003 DE-627
005 20230428055209.0
007 cr uuu---uuuuu
008 200304s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ijcard.2018.08.082  |2 doi 
035 |a (DE-627)1691563080 
035 |a (DE-599)KXP1691563080 
035 |a (OCoLC)1341309367 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Höper, Marius  |d 1963-  |e VerfasserIn  |0 (DE-588)130336408  |0 (DE-627)498447251  |0 (DE-576)298134691  |4 aut 
245 1 0 |a Targeted therapy of pulmonary arterial hypertension  |b updated recommendations from the Cologne Consensus Conference 2018  |c Marius M. Hoeper, Christian Apitz, Ekkehard Grünig, Michael Halank, Ralf Ewert, Harald Kaemmerer, Hans-Joachim Kabitz, Christian Kähler, Hans Klose, Hanno Leuchte, Silvia Ulrich, Karen M. Olsson, Oliver Distler, Stephan Rosenkranz, H. Ardeschir Ghofrani 
264 1 |c 25 August 2018 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.03.2020 
520 |a In the summer of 2016, delegates from the German Respiratory Society, the German Society of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to define consensus-based practice recommendations for the management of patients with pulmonary arterial hypertension (PAH). These recommendations were built on the 2015 European Pulmonary Hypertension guidelines and included new evidence, where available. The treatment algorithm for PAH was modified based on the observation that there are now many patients diagnosed with IPAH who are at an advanced age and have significant cardiopulmonary comorbidities. For patients newly diagnosed with classic forms of PAH, i.e. younger patients without significant cardiopulmonary comorbidities, the consensus-based recommendation was to use initial combination therapy as the standard approach. The use of monotherapies was no longer considered appropriate in such patients. The choice of treatment strategies should be based on the risk assessment as proposed in the European guidelines. In patients presenting with a low or intermediate risk, oral combination therapy with endothelin receptor antagonists and phosphodiesterase-5 inhibitors or soluble guanylate cyclase stimulators, respectively, should be used. In high-risk patients, triple combination therapy including a subcutaneous or intravenous prostacyclin analogue should be considered. For patients who suffer from PAH and significant cardiopulmonary comorbidities, initial monotherapy is recommended and the use of combination therapies should be considered on an individual basis. The latter recommendations are based on the scarcity of evidence supporting the use of combination therapy and the higher risk of drug-related adverse events in such patients. 
650 4 |a Endothelin receptor antagonists 
650 4 |a Phosphodiesterase-5 inhibitors 
650 4 |a Prostacyclin analogues 
650 4 |a Pulmonary arterial hypertension 
650 4 |a Pulmonary hypertension 
650 4 |a sGC stimulators 
650 4 |a Therapy 
700 1 |a Apitz, Christian  |e VerfasserIn  |4 aut 
700 1 |a Grünig, Ekkehard  |e VerfasserIn  |0 (DE-588)112535801  |0 (DE-627)618892605  |0 (DE-576)31856694X  |4 aut 
700 1 |a Halank, Michael  |e VerfasserIn  |4 aut 
700 1 |a Ewert, Ralf  |e VerfasserIn  |4 aut 
700 1 |a Kaemmerer, Harald  |e VerfasserIn  |4 aut 
700 1 |a Kabitz, Hans-Joachim  |e VerfasserIn  |4 aut 
700 1 |a Kähler, Christian  |e VerfasserIn  |4 aut 
700 1 |a Klose, Hans  |e VerfasserIn  |4 aut 
700 1 |a Leuchte, Hanno  |e VerfasserIn  |4 aut 
700 1 |a Ulrich, Silvia  |e VerfasserIn  |4 aut 
700 1 |a Olsson, Karen M.  |e VerfasserIn  |4 aut 
700 1 |a Distler, Oliver  |e VerfasserIn  |4 aut 
700 1 |a Rosenkranz, Stephan  |e VerfasserIn  |4 aut 
700 1 |a Ghofrani, H. Ardeschir  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cardiology  |d Amsterdam [u.a.] : Elsevier Science, 1981  |g 272(2018), Seite 37-45  |h Online-Ressource  |w (DE-627)306659581  |w (DE-600)1500478-8  |w (DE-576)081986270  |x 1874-1754  |7 nnas  |a Targeted therapy of pulmonary arterial hypertension updated recommendations from the Cologne Consensus Conference 2018 
773 1 8 |g volume:272  |g year:2018  |g pages:37-45  |g extent:9  |a Targeted therapy of pulmonary arterial hypertension updated recommendations from the Cologne Consensus Conference 2018 
856 4 0 |u https://doi.org/10.1016/j.ijcard.2018.08.082  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0167527318343493  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20200304 
993 |a ConferencePaper 
994 |a 2018 
998 |g 112535801  |a Grünig, Ekkehard  |m 112535801:Grünig, Ekkehard  |d 910000  |d 950000  |d 950900  |e 910000PG112535801  |e 950000PG112535801  |e 950900PG112535801  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 3 
999 |a KXP-PPN1691563080  |e 3603851358 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 04.03.2020"],"recId":"1691563080","name":{"displayForm":["Marius M. Hoeper, Christian Apitz, Ekkehard Grünig, Michael Halank, Ralf Ewert, Harald Kaemmerer, Hans-Joachim Kabitz, Christian Kähler, Hans Klose, Hanno Leuchte, Silvia Ulrich, Karen M. Olsson, Oliver Distler, Stephan Rosenkranz, H. Ardeschir Ghofrani"]},"relHost":[{"disp":"Targeted therapy of pulmonary arterial hypertension updated recommendations from the Cologne Consensus Conference 2018International journal of cardiology","pubHistory":["1.1981 -"],"recId":"306659581","note":["Gesehen am 13.02.20","Ungezählte Beil.: Supplement"],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1981-","publisher":"Elsevier Science","dateIssuedKey":"1981"}],"id":{"eki":["306659581"],"issn":["1874-1754"],"zdb":["1500478-8"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"part":{"year":"2018","extent":"9","volume":"272","pages":"37-45","text":"272(2018), Seite 37-45"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"International journal of cardiology","title":"International journal of cardiology"}]}],"person":[{"role":"aut","given":"Marius","family":"Höper","display":"Höper, Marius"},{"display":"Apitz, Christian","family":"Apitz","given":"Christian","role":"aut"},{"given":"Ekkehard","family":"Grünig","display":"Grünig, Ekkehard","role":"aut"},{"role":"aut","given":"Michael","family":"Halank","display":"Halank, Michael"},{"role":"aut","given":"Ralf","family":"Ewert","display":"Ewert, Ralf"},{"display":"Kaemmerer, Harald","family":"Kaemmerer","given":"Harald","role":"aut"},{"family":"Kabitz","display":"Kabitz, Hans-Joachim","given":"Hans-Joachim","role":"aut"},{"display":"Kähler, Christian","family":"Kähler","given":"Christian","role":"aut"},{"role":"aut","given":"Hans","display":"Klose, Hans","family":"Klose"},{"role":"aut","given":"Hanno","display":"Leuchte, Hanno","family":"Leuchte"},{"given":"Silvia","family":"Ulrich","display":"Ulrich, Silvia","role":"aut"},{"family":"Olsson","display":"Olsson, Karen M.","given":"Karen M.","role":"aut"},{"role":"aut","given":"Oliver","family":"Distler","display":"Distler, Oliver"},{"role":"aut","display":"Rosenkranz, Stephan","family":"Rosenkranz","given":"Stephan"},{"given":"H. Ardeschir","display":"Ghofrani, H. Ardeschir","family":"Ghofrani","role":"aut"}],"physDesc":[{"extent":"9 S."}],"title":[{"title_sort":"Targeted therapy of pulmonary arterial hypertension","title":"Targeted therapy of pulmonary arterial hypertension","subtitle":"updated recommendations from the Cologne Consensus Conference 2018"}],"id":{"doi":["10.1016/j.ijcard.2018.08.082"],"eki":["1691563080"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"25 August 2018"}]} 
SRT |a HOEPERMARITARGETEDTH2520